1. Home
  2. SKLZ vs ELTX Comparison

SKLZ vs ELTX Comparison

Compare SKLZ & ELTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SKLZ
  • ELTX
  • Stock Information
  • Founded
  • SKLZ 2012
  • ELTX 2011
  • Country
  • SKLZ United States
  • ELTX United States
  • Employees
  • SKLZ N/A
  • ELTX N/A
  • Industry
  • SKLZ EDP Services
  • ELTX Biotechnology: Pharmaceutical Preparations
  • Sector
  • SKLZ Technology
  • ELTX Health Care
  • Exchange
  • SKLZ Nasdaq
  • ELTX Nasdaq
  • Market Cap
  • SKLZ 136.4M
  • ELTX 121.7M
  • IPO Year
  • SKLZ N/A
  • ELTX N/A
  • Fundamental
  • Price
  • SKLZ $7.22
  • ELTX $11.50
  • Analyst Decision
  • SKLZ Buy
  • ELTX Strong Buy
  • Analyst Count
  • SKLZ 1
  • ELTX 2
  • Target Price
  • SKLZ $14.00
  • ELTX $11.00
  • AVG Volume (30 Days)
  • SKLZ 63.8K
  • ELTX 101.1K
  • Earning Date
  • SKLZ 11-06-2025
  • ELTX 11-12-2025
  • Dividend Yield
  • SKLZ N/A
  • ELTX N/A
  • EPS Growth
  • SKLZ N/A
  • ELTX N/A
  • EPS
  • SKLZ N/A
  • ELTX N/A
  • Revenue
  • SKLZ $93,320,000.00
  • ELTX N/A
  • Revenue This Year
  • SKLZ $17.44
  • ELTX N/A
  • Revenue Next Year
  • SKLZ $12.03
  • ELTX N/A
  • P/E Ratio
  • SKLZ N/A
  • ELTX N/A
  • Revenue Growth
  • SKLZ N/A
  • ELTX N/A
  • 52 Week Low
  • SKLZ $3.54
  • ELTX $4.05
  • 52 Week High
  • SKLZ $9.11
  • ELTX $12.62
  • Technical
  • Relative Strength Index (RSI)
  • SKLZ 40.76
  • ELTX 56.79
  • Support Level
  • SKLZ $7.00
  • ELTX $10.00
  • Resistance Level
  • SKLZ $7.54
  • ELTX $11.89
  • Average True Range (ATR)
  • SKLZ 0.30
  • ELTX 0.71
  • MACD
  • SKLZ -0.12
  • ELTX -0.05
  • Stochastic Oscillator
  • SKLZ 11.17
  • ELTX 57.25

About SKLZ Skillz Inc.

Skillz Inc is a mobile game development company. It is engaged in re-inventing competitive mobile gaming and thereby expanding the mobile gaming market. Some of the games available on its platform are Dominoes Gold, Blackout Bingo, 21 Blitz, and Solitaire Cube among others. The company's reportable business segments are; the Skillz segment and the Aarki segment. The majority of its revenue is generated from the Skillz segment which is an eSports gaming platform, enabling game developers to monetize their content through multi-player competition. Geographically, the company derives its key revenue from the United States and the rest from Israel, China, Malta, and other countries.

About ELTX Elicio Therapeutics Inc.

Elicio Therapeutics Inc is a clinical-stage biotechnology company pioneering the development of cancer immunotherapies for patients with limited treatment options and poor outcomes. Its proprietary Amphiphile, or AMP, platform delivers investigational immunotherapeutics directly to the brain center of the immune system the lymph nodes. Its focus is the development of cancer immunotherapies against biologically validated but hard-to-drug targets that can be activated through lymph node trafficking. Elicio is engineering lymph node-targeted AMPlifiers, immunomodulators, adjuvants, and vaccines for an array of aggressive cancers. It has developed its cancer vaccine product candidates to target biologically validated tumor mutation drivers using known neoantigens.

Share on Social Networks: